News
Hydroxychloroquine May Tame Preeclampsia in Lupus Patients Hydroxychloroquine is tied to reduced preeclampsia risk but not preterm birth risk in pregnant patients with lupus in a Swedish cohort ...
Lupus affects different people in different ways, and skin problems like rashes or sores re common. In a new study, people with systemic lupus erythematosus (SLE) were found to be at higher risk for ...
A new study looked at the possibility of a causal relationship between interleukin-18 (IL-18) cytokine and the risk of inflammatory and autoimmune diseases such as systemic lupus erythematosus (SLE).
Current treatment options for systemic lupus erythematosus (SLE) consists of glucocorticoids, antimalarials, immunosuppressives, and a few biologics, approved or of 'off-label'. Through judicious ...
References 1. FDA approves Benlysta (belimumab) autoinjector for children with systemic lupus erythematosus. News release. GSK. May 20, 2024.
ANSWER: Systemic lupus erythematosus (SLE) is a multisystem autoimmune disease, while cutaneous lupus are a group of diseases where lupus is localized to the skin. Systemic lupus often includes ...
About Enpatoran Enpatoran is a selective Toll-like receptor (TLR)7/8 inhibitor under investigation for the treatment of systemic lupus erythematosus (SLE) and cutaneous lupus erythematosus (CLE).
Topline results were announced from a phase 3 trial evaluating dapirolizumab pegol in patients with moderate to severe systemic lupus erythematosus (SLE). Dapirolizumab pegol is an investigational ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results